Insider trades
Parschauer Karah Herdman, CLO of Ultragenyx Pharmaceutical RARE, has filed 0 purchases and 14 sales on the open market. Over the past 12 months that comes to a net sale of $440.5K. The latest trade was on 06/15.
Parschauer Karah Herdman
EVP and Chief Legal Officer
- First filing
- 23/01/31
- Trades
- 37 trades
- Buys / sales
- 0 / 14
- 12-month net buying
- −$440.5K
- Last trade
- 06/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/15 | 06/15 | 1,899 sh | $24.62 | $46,753.38 | −2.0% | |
RARE | Open-market sale | 03/06–03/10 | 03/10 | 9,526 sh2 trades | $21.87avg. | $208,311.56 | −12.5% |
| Open-market sale | 03/02 | 03/03 | 8,135 sh | $22.80 | $185,478 | −9.6% | |
| Open-market sale | 25/09/12 | 25/09/12 | 2,450 sh | $31.17 | $76,366.5 | −3.2% | |
EvolusEOLS | Open-market sale | 25/03/12 | 25/03/14 | 12,888 sh | $12.99 | $167,415.12 | −28.6% |
| Open-market sale | 25/03/03 | 25/03/04 | 12,846 sh | $42.10 | $540,816.6 | −14.6% | |
RARE | Open-market sale | 25/02/27 | 25/03/03 | 2,990 sh2 trades | $42.88avg. | $128,223.9 | −5.2% |
| Open-market sale10b5-1 plan | 24/06/12 | 24/06/12 | 9,806 sh | $45.00 | $441,270 | −14.5% | |
| Open-market sale | 24/03/01 | 24/03/05 | 3,756 sh | $53.76 | $201,922.56 | −5.3% | |
EvolusEOLS | Open-market sale10b5-1 plan | 24/01/30 | 24/02/02 | 11,931 sh | $13.14 | $156,773.34 | −27.6% |
| Open-market sale | 23/05/04 | 23/05/05 | 4,378 sh | $45.00 | $197,010 | −7.8% | |
| Open-market sale | 23/03/01 | 23/03/03 | 3,161 sh | $45.25 | $143,035.25 | −5.3% |
